-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the Bengbu Market Supervision and Administration Bureau issued a notice on the cancellation of the "Drug Business License".
The notice shows that according to the application of Bengbu Haozhijia Pharmacy Co.
, Ltd.
License is cancelled
.
Bengbu Haozhijia Pharmacy Co.
, Ltd.
is a single retail enterprise.
Its business scope includes: prescription drugs, non-prescription drugs: Chinese patent medicines, chemical preparations, antibiotics, biochemical drugs, biological products, Chinese medicine decoction pieces (limited packaging)
.
It is worth mentioning that the license period of this enterprise is from May 26, 2020 to May 25, 2025
.
In other words, the enterprise chose to withdraw from the market within 2 years of obtaining the license
.
In addition to hospitals, drug retail enterprises are another channel for drugs to enter the consumption link, and they are also an important business entity in the drug service system.
The upstream is a drug wholesale enterprise or a drug production enterprise, and the downstream is the end customer
.
According to data, the sales of drug retail enterprises have accounted for 15% of the market share of all drug sales
.
In recent years, with the help of favorable policies, the pharmaceutical retail industry has ushered in a new round of growth space and is expected to maintain a good momentum of continued growth
.
But at the same time, the industry also faces supply chain and regulatory compliance challenges
.
Recently, a large number of drug retail enterprises have been inspected and found to be unqualified
.
For example, on March 3, the Municipal Supervision Bureau of Ma'anshan City, Anhui Province issued a monthly report on the supervision and inspection of the circulation of medicines and equipment (Ma'anshan) for February 2022
.
Among them, 34 single drugstores and chain stores were inspected, 7 enterprises were rectified within a time limit, and 27 were qualified enterprises
.
Judging from the main problems found in the rectification of enterprises within a time limit, including the storage of daily items irrelevant to business operations in the business premises, incomplete temperature and humidity records in normal temperature areas, and irregular temperature and humidity records
.
On March 2, the Chuzhou Municipal Bureau of Supervision, Anhui Province issued a public announcement on the supervision and inspection of the circulation of pharmaceutical equipment in Chuzhou (February 2022)
.
Among them, 125 single drugstores and chain stores were inspected, 3 unqualified enterprises, 14 rectification enterprises within a time limit, and 108 qualified enterprises
.
Among them, the three unqualified enterprises are mainly: the suspected case of failing to obtain and retain the purchase certificate for the drugs they operated; the suspected licensed pharmacist not selling prescription drugs; the suspected failure to maintain the drugs
.
For another example, on January 25, the Municipal Supervision Bureau of Huaiyuan County, Anhui Province issued a monthly report on the supervision and inspection of the mechanized circulation of medicines (2022.
1)
.
Among them, 76 enterprises were inspected for retail drugstores and chain stores, 19 enterprises were unqualified (referring to those subject to administrative punishment), 1 enterprise rectified within a time limit, and 56 qualified enterprises
.
Judging from the main problems found in the inspection of unqualified enterprises, they mainly involved suspected sales of prescriptions without prescriptions, and sales of prescription drugs by licensed pharmacists who were not on duty
.
From the perspective of the industry environment, the pharmacy industry has entered the era of "stock competition".
In the context of improved industry compliance and rising costs in various aspects, the industry believes that compared with chain giants with anti-risk capabilities In other words, the survival space of single drug retail enterprises will become smaller and smaller, and in the case of weak operation, it is also expected that a large number of enterprises will be accelerated out of the market
.
According to the "Guiding Opinions on Promoting the High-Quality Development of the Drug Circulation Industry During the "14th Five-Year Plan" Period issued by the Ministry of Commerce, by 2025, it is necessary to cultivate and form 5-10 specialized and diversified drug retailers with a value of over 50 billion yuan.
The annual sales of chain enterprises and top 100 pharmaceutical retail companies account for more than 65% of the total pharmaceutical retail market, and the drug retail chain rate is close to 70%
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
The notice shows that according to the application of Bengbu Haozhijia Pharmacy Co.
, Ltd.
License is cancelled
.
Bengbu Haozhijia Pharmacy Co.
, Ltd.
is a single retail enterprise.
Its business scope includes: prescription drugs, non-prescription drugs: Chinese patent medicines, chemical preparations, antibiotics, biochemical drugs, biological products, Chinese medicine decoction pieces (limited packaging)
.
It is worth mentioning that the license period of this enterprise is from May 26, 2020 to May 25, 2025
.
In other words, the enterprise chose to withdraw from the market within 2 years of obtaining the license
.
In addition to hospitals, drug retail enterprises are another channel for drugs to enter the consumption link, and they are also an important business entity in the drug service system.
The upstream is a drug wholesale enterprise or a drug production enterprise, and the downstream is the end customer
.
According to data, the sales of drug retail enterprises have accounted for 15% of the market share of all drug sales
.
In recent years, with the help of favorable policies, the pharmaceutical retail industry has ushered in a new round of growth space and is expected to maintain a good momentum of continued growth
.
But at the same time, the industry also faces supply chain and regulatory compliance challenges
.
Recently, a large number of drug retail enterprises have been inspected and found to be unqualified
.
For example, on March 3, the Municipal Supervision Bureau of Ma'anshan City, Anhui Province issued a monthly report on the supervision and inspection of the circulation of medicines and equipment (Ma'anshan) for February 2022
.
Among them, 34 single drugstores and chain stores were inspected, 7 enterprises were rectified within a time limit, and 27 were qualified enterprises
.
Judging from the main problems found in the rectification of enterprises within a time limit, including the storage of daily items irrelevant to business operations in the business premises, incomplete temperature and humidity records in normal temperature areas, and irregular temperature and humidity records
.
On March 2, the Chuzhou Municipal Bureau of Supervision, Anhui Province issued a public announcement on the supervision and inspection of the circulation of pharmaceutical equipment in Chuzhou (February 2022)
.
Among them, 125 single drugstores and chain stores were inspected, 3 unqualified enterprises, 14 rectification enterprises within a time limit, and 108 qualified enterprises
.
Among them, the three unqualified enterprises are mainly: the suspected case of failing to obtain and retain the purchase certificate for the drugs they operated; the suspected licensed pharmacist not selling prescription drugs; the suspected failure to maintain the drugs
.
For another example, on January 25, the Municipal Supervision Bureau of Huaiyuan County, Anhui Province issued a monthly report on the supervision and inspection of the mechanized circulation of medicines (2022.
1)
.
Among them, 76 enterprises were inspected for retail drugstores and chain stores, 19 enterprises were unqualified (referring to those subject to administrative punishment), 1 enterprise rectified within a time limit, and 56 qualified enterprises
.
Judging from the main problems found in the inspection of unqualified enterprises, they mainly involved suspected sales of prescriptions without prescriptions, and sales of prescription drugs by licensed pharmacists who were not on duty
.
From the perspective of the industry environment, the pharmacy industry has entered the era of "stock competition".
In the context of improved industry compliance and rising costs in various aspects, the industry believes that compared with chain giants with anti-risk capabilities In other words, the survival space of single drug retail enterprises will become smaller and smaller, and in the case of weak operation, it is also expected that a large number of enterprises will be accelerated out of the market
.
According to the "Guiding Opinions on Promoting the High-Quality Development of the Drug Circulation Industry During the "14th Five-Year Plan" Period issued by the Ministry of Commerce, by 2025, it is necessary to cultivate and form 5-10 specialized and diversified drug retailers with a value of over 50 billion yuan.
The annual sales of chain enterprises and top 100 pharmaceutical retail companies account for more than 65% of the total pharmaceutical retail market, and the drug retail chain rate is close to 70%
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
